RxDoctor Payments Data

Bushra Aziz, MD

Psychiatry · Dallas, TXNPI 1730392549

Payments from drug & device makers

$1,014in general payments, 2019–2025

Across 23 payments — averaging $44.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$482
  • Sunovion Pharmaceuticals Inc.$93
  • Teva Pharmaceuticals USA, Inc.$86
  • Otsuka America Pharmaceutical, Inc.$74
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$72
  • Lundbeck LLC$41
  • plus $167 from 6 others

What the payments were for

  • Food & beverage$44784%
  • Education$8616%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,014 in reported general payments places this provider in the 65th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$132,963
Medicare patients
229
Services billed
1,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$107,545
Aripiprazole227$33,700
Abilify MaintenaAripiprazole12$32,767
Lurasidone Hcl44$21,702
Hydroxyzine Hcl334$4,588
Paliperidone ErPaliperidone19$3,705
Quetiapine Fumarate298$3,125
Chlorpromazine Hcl14$2,403
Duloxetine Hcl119$2,104
Divalproex Sodium ErDivalproex Sodium46$2,062
Buspirone Hcl203$1,787
Trazodone Hcl336$1,530
Risperidone118$1,523
Bupropion XlBupropion Hcl80$1,363
Haloperidol41$1,115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$39$107,54513 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$74$32,76712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →